AE	adverse event
AI-DILI	autoimmune DILI
AIH	autoimmune hepatitis
ANA	antinuclear antigen
APC	antigen-presenting cell
APAP	acetaminophen
ATP	adenosine triphosphate
CD	cluster of differentiation
CTLA4	cytotoxic T-lymphocyte-associated protein 4
DAMP	damage-associated molecular pattern
DC	dendritic cell
DILI	drug-induced liver injury
FasL	Fas ligand
GSH	glutathione
GWAS	genome-wide association studies
HLA	human leukocyte antigen
HMGB1	high mobility group box-1
ICAM	intercellular adhesion molecule
ICI	immune checkpoint inhibitor
IFN-γ	interferon gamma
iDILI	idiosyncratic drug-induced liver injury
IL	interleukin
iNKT	invariant NKT cell
K18	keratin 18
KC	Kupffer cell
LN	lymph node
LPS	lipopolysaccharide
MHC	major histocompatibility complex
MMP	metalloproteinase
NKT	natural killer T cell
NLR	NOD-like receptor
NO	nitric oxide
PAMP	pathogen-associated molecular pattern
PD-1	programmed cell death protein 1
PD-L1	programmed cell death ligand 1
PRS	polygenic risk score
PTPN22	lymphoid-specific protein tyrosine phosphatase non-receptor type 22
RLR	RIG-like receptor
ROS	reactive oxygen species
SMA	smooth muscle antigen
SNP	single nucleotide polymorphism
SOD	superoxide dismutase
TCR	T cell receptor
Th	T helper cell
TLR	Toll-like receptor
TNF-α	tumor necrosis factor alpha
TRAIL	TNF-related apoptosis-inducing ligand
Treg	regulatory T cell
VCAM	vascular cell adhesion molecule
VEGF	vascular endothelial growth factor